Lars Egevad
Overview
Explore the profile of Lars Egevad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
358
Citations
9420
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egevad L, Micoli C, Delahunt B, Samaratunga H, Garmo H, Stattin P, et al.
J Clin Pathol
. 2025 Mar;
PMID: 40081884
Reporting of prostate cancer grade has drifted to higher reported grades over the past decades. In prostate cancers diagnosed on needle biopsy of 1 72 112 men reported to The...
2.
Egevad L, Micoli C, Delahunt B, Samaratunga H, Garmo H, Stattin P, et al.
Pathology
. 2025 Feb;
57(3):293-296.
PMID: 39924438
Prostate cancer grade is currently often reported both by Gleason scores and by grouping of the scores into five so-called International Society of Urological Pathology (ISUP) grades (also known as...
3.
Ji X, Salmon R, Mulliqi N, Khan U, Wang Y, Blilie A, et al.
Mod Pathol
. 2025 Jan;
38(5):100715.
PMID: 39826798
The potential of artificial intelligence (AI) in digital pathology is limited by technical inconsistencies in the production of whole slide images (WSIs). This causes degraded AI performance and poses a...
4.
Roldan F, Falagario U, Olsson M, Salas R, Aly M, Egevad L, et al.
BJUI Compass
. 2024 Sep;
5(9):885-892.
PMID: 39323926
Objective: The aim of this study is to evaluate treatment patterns and long-term oncological outcomes of patients with locally advanced prostate cancer (LAPCa). Patients And Methods: This is a population-based...
5.
Hugosson J, Arnsrud Godtman R, Wallstrom J, Axcrona U, Bergh A, Egevad L, et al.
N Engl J Med
. 2024 Sep;
391(12):1083-1095.
PMID: 39321360
Background: Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. Methods: In a population-based trial that...
6.
Samaratunga H, Delahunt B, Olsson M, Aly M, Egevad L, Yaxley J
Pathology
. 2024 Sep;
56(7):1059-1061.
PMID: 39237382
No abstract available.
7.
Du X, Hao S, Olsson H, Kartasalo K, Mulliqi N, Rai B, et al.
Eur Urol Oncol
. 2024 May;
8(1):80-86.
PMID: 38789385
Background And Objective: Image-based artificial intelligence (AI) methods have shown high accuracy in prostate cancer (PCa) detection. Their impact on patient outcomes and cost effectiveness in comparison to human pathologists...
8.
Egevad L, Micoli C, Delahunt B, Samaratunga H, Orrason A, Garmo H, et al.
Virchows Arch
. 2024 Apr;
484(6):995-1003.
PMID: 38683251
A 5-tier grouping of Gleason scores has recently been proposed. Studies have indicated prognostic heterogeneity within these groups. We assessed prostate cancer-specific mortality (PCSM) and all-cause mortality (ACM) for men...
9.
Thomsen F, Garmo H, Egevad L, Stattin P, Brasso K
Scand J Urol
. 2024 Apr;
59:76-83.
PMID: 38682731
Background And Objectives: Changes in work-up and histopathological assessment have caused stage and grade migration in men with prostate cancer (PCa). The aim of this study was to assess temporal...
10.
Pellegrino F, Falagario U, Knipper S, Martini A, Akre O, Egevad L, et al.
Eur Urol Oncol
. 2023 Dec;
7(4):888-896.
PMID: 38155061
Background: Positive surgical margins (PSMs) are frequent in patients undergoing radical prostatectomy (RP). The impact of PSMs on cancer-specific (CSM) and overall (OM) mortality has not yet been proved definitively....